Mitochondrial ATP dependent potassium channels mediate non-ischemic preconditioning by tachycardia in dogs

Molecular and Cellular Biochemistry

Volumn 216, Issue 1-2, 2001, Pages 129-136

  Macho, P ^a   Solis E ^b   Sanchez G ^a   Schwarze, H ^a   Domenech, R ^c  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD DE PANAMÁ   (Panama)

^c NONE   (Chile)

Author keywords

5 Hydroxydecanoate; Glibenclamide; Mitochondrial ATP dependent potassium channels; Preconditioning; Tachycardia

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE; GLIBENCLAMIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; FEMALE; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART RATE; MALE; NONHUMAN; POTASSIUM TRANSPORT; TACHYCARDIA;

ANIMALIA; CANIS FAMILIARIS;

EID: 0035130301     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011032218794     Document Type: Article

References (31)

1. Tachycardia preconditions the infarct size in dogs. Role of adenosine and protein kinase C
2. Blockade of ischemic preconditioning in dogs by a novel ATP dependent potassium channels antagonist 5-hydroxydecanoate
3. Mitochondrial ATP-dependent potassium channels. Viable candidate effectors of ischemic preconditioning
4. + channels by protein kinase C
5. A simple technique for production of chronic complete heart block in dogs
6. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen
7. Effect of endothelin on total and regional coronary resistance and on myocardial contractility
8. Some sources of error measuring regional flow with radioactive microspheres
9. +channels, attenuates metabolic coronary vasodilatation induced by pacing tachycardia in dogs
10. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs
11. Adenosine A-1 receptors, K-ATP channels, and ischemic preconditioning in dogs
12. Ketamine-xylazine anaesthesia permits a K-ATP channel antagonist to attenuate preconditioning in rabbit myocardium
13. Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine
14. The ischemia selective K-ATP channel antagonist, 5HD, blocks ischemic preconditioning in the rat heart
15. +channel? Studies of contractile function after stimulated ischemia in an atrial in vitro model
16. Glibenclamide does not abolish the protection effect of preconditioning on stunning in the isolated perfused rat heart
17. ATP channels are common mediators of ischemic and calcium preconditioning in rabbits
18. Stretch-induced protection shares a common mechanism with ischemic preconditioning in rabbit heart
19. Blockade of ATP ATP-sensitive channels increases infarct size but does not prevent preconditioning in rabbit hearts
20. Rapid ventricular pacing produces myocardial protection by nonischemic activation of ATP potassium channels
21. +channels by protein kinase C
22. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model?
23. No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine
24. Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia
25. Effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size
26. A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs: Efficacy, time course and role of K-ATP channels
27. Ischemic preconditioning depends on interaction between mitochondrial K-ATP channels and actin cytoskeleton
28. Activation of mitogen-activated protein kinases (p38-MAPKs, SAPKs/JNKs and ERKs) by adenosine in the perfused rat heart
29. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide
30. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase: Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning
31. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway